European Life Sciences Perspective: Current Trends and Brexit Implications — Session 1

The life sciences industry is undergoing transformation across the globe and facing challenges and opportunities arising from the coronavirus (COVID-19) pandemic. In addition, the United Kingdom’s exit from the European Union is expected to bring significant changes for the industry in relation to issues including pharmaceutical and medical device regulation, antitrust and competition, and corporate transactions.

Please join us for a two-part webinar series on key legal, employment, and regulatory trends and issues impacting the European life sciences market.

Session 1: Employment, Data Protection, and Regulatory Trends in the European Life Sciences Market
Thursday, October 1, 2020
11:00 am –12:00 pm ET | 4:00–5:00 pm BST

Louise Skinner, Partner, Labour & Employment
Pulina Whitaker, Partner, Labour & Employment
Paul Ranson, Consultant, Corporate

Questions? Please contact stephanie.steedman@morganlewis.com

Don't miss Session 2: Corporate, Competition, IP, and Collaboration Trends in the European Life Sciences Market on October 7.